Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients, the GFM experience: response to Bowenet al

Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients

(2013) Laurent Pascal et al.   BRITISH JOURNAL OF HAEMATOLOGY

How I treat transfusional iron overload

(2012) A. V. Hoffbrand et al.   BLOOD

MRI-Based Liver Iron Content Predicts for Nonrelapse Mortality in MDS and AML Patients Undergoing Allogeneic Stem Cell Transplantation

(2012) M. Wermke et al.   CLINICAL CANCER RESEARCH

The relationship between cardiac and liver iron evaluated by MR imaging in haematological malignancies and chronic liver disease

(2012) J M Virtanen et al.   Blood Cancer Journal

Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM

(2010) Christian Rose et al.   LEUKEMIA RESEARCH

Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts

(2008) Cheng E. Chee et al.   AMERICAN JOURNAL OF HEMATOLOGY

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload

(2008) Norbert Gattermann   INTERNATIONAL JOURNAL OF HEMATOLOGY